Детские злокачественные новообразования и их учет: мировые и отечественные тенденции
АР Волкова, ХМ Вахитов… - … детской гематологии и …, 2020 - cyberleninka.ru
Злокачественные новообразования занимают одно из ведущих мест в структуре
детской смертности. В представленной статье приведен обзор современных сведений …
детской смертности. В представленной статье приведен обзор современных сведений …
Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins
C Gonçalves, SR Martins-Neves, D Paiva-Oliveira… - Life sciences, 2015 - Elsevier
Aims Osteosarcoma is the most common pediatric bone malignancy with high propensity to
metastasize and relapse. Emerging evidence suggest that osteosarcoma is sustained by a …
metastasize and relapse. Emerging evidence suggest that osteosarcoma is sustained by a …
The BRAF activated non‐coding RNA: A pivotal long non‐coding RNA in human malignancies
XF Liu, JL Hao, T Xie, OP Pant, CB Lu, CW Lu… - Cell …, 2018 - Wiley Online Library
Long non‐coding RNA s (lnc RNA s) participate in the complex network of cancer and play
an important role in tumourigenesis and progression. BRAF activated non‐coding RNA …
an important role in tumourigenesis and progression. BRAF activated non‐coding RNA …
Outcome of childhood acute lymphoblastic leukemia treated using the Thai national protocols
P Seksarn, S Wiangnon, G Veerakul… - Asian pacific journal …, 2015 - koreascience.kr
Background: In recent decades, the prognosis for childhood leukemia has improved,
especially for acute lymphoblastic leukemia (ALL). In Thailand, though, the survival rate for …
especially for acute lymphoblastic leukemia (ALL). In Thailand, though, the survival rate for …
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of …
Blinatumomab, a bispecific T cell-engaging antibody, has demonstrated efficacy for relapsed
or refractory acute lymphoblastic leukemia (ALL). In this study, we evaluated the efficacy and …
or refractory acute lymphoblastic leukemia (ALL). In this study, we evaluated the efficacy and …
Surgical management of follicular thyroid carcinoma in children and adolescents: A study of 30 cases
C Spinelli, L Rallo, R Morganti, V Mazzotti… - Journal of pediatric …, 2019 - Elsevier
Abstract Background/Purpose The purpose of the study is to describe the anatomoclinical,
diagnostic, therapeutic and prognostic aspects of pediatric follicular thyroid carcinoma (FTC) …
diagnostic, therapeutic and prognostic aspects of pediatric follicular thyroid carcinoma (FTC) …
[HTML][HTML] The combination of olaratumab with doxorubicin and cisplatinum regresses a chemotherapy-resistant osteosarcoma in a patient-derived orthotopic xenograft …
Chemotherapy-resistant osteosarcoma is a recalcitrant disease. It is a frequent cause of
death to the patients who are usually adolescent or young adults. The goal of the present …
death to the patients who are usually adolescent or young adults. The goal of the present …
Cross-sectional study of characteristics of clinical registries in Australia: a resource for clinicians and policy makers
D Md. Emdadul Hoque, R Ruseckaite… - … Journal for Quality in …, 2018 - academic.oup.com
Objectives To investigate the attributes of Australian clinical quality registries (CQR). Design
and setting Survey of 40 CQRs between September 2015 and April 2016. Participants CQR …
and setting Survey of 40 CQRs between September 2015 and April 2016. Participants CQR …
Understanding clinical trials in childhood cancer
MC Bond, S Pritchard - Paediatrics & child health, 2006 - academic.oup.com
Clinical trials in paediatric cancer continue to be a key factor in progress toward better
treatment and prognosis. Paediatricians and family physicians may be asked by patients …
treatment and prognosis. Paediatricians and family physicians may be asked by patients …
End‐of‐life care in pediatric neuro‐oncology
SG Vallero, S Lijoi, D Bertin, LS Pittana… - Pediatric blood & …, 2014 - Wiley Online Library
Background The management of children with cancer during the end‐of‐life (EOL) period is
often difficult and requires skilled medical professionals. Patients with tumors of the central …
often difficult and requires skilled medical professionals. Patients with tumors of the central …